control of other genes, e.g. p21 waf1/cip1, MDM2, and Gadd45 (1). Induction of p21 waf1/cip1 expression by p53 may block the
the p53 gene have been found in 50% of the human tumours The tumour suppressor gene p53 is expressed in response in a wide variety of organs including colon, lung, bladder, to DNA-damage; its protein product blocks cells in the G1-ovary, and skin (6). Loss of p53 function may have important phase of the cell cycle. This gives cells additional time to consequences for the cell although p53 does not appear to be repair their DNA-damage. However, it may trigger essential for cell cycle regulation under normal developmental apoptosis if damage is too high. Loss of p53 function conditions: mice lacking the p53 gene develop and grow appears to be an important step in carcinogenesis because normally, although they are tumour-prone (7, 8 ). An important 50% of human tumours have lost functional p53. In order physiological function of p53, however, seems to be regulating to study the role of p53 in experimental hepatocarcinothe cell cycle after induction of DNA damage by blocking the genesis, we determined the expression of p53 in rat liver cell cycle in G1-phase. This allows the cell to repair its DNAin response to various hepatocarcinogenic and hepatotoxic damage, or may trigger apoptosis (9-11). Therefore, p53 has compounds. Administration of hepatocarcinogenic combeen regarded as a guardian of the genome (12). pounds increased p53 protein levels in the liver as detected Levels of p53 protein are increased by various types of by immunoprecipitation followed by SDS-PAGE and genetic damage such as cytostatic drugs, UV radiation, and
Western blotting with ECL-detection. The hepatocarcinobenzo[a]pyrene (B[a]P*) (13-22). One of the mechanisms gens included N-hydroxy-2-acetylaminofluorene, aflatoxin
probably involves recognition of DNA damage by a DNA-B1, and diethylnitrosamine. Their structural analogues activated protein kinase and subsequent phosphorylation and N-hydroxy-4-acetylaminobiphenyl and ethyl methanestabilisation of the p53 protein (23,24). sulphonate which are not hepatocarcinogenic, did not It has been suggested that p53 has a dual role in tumour induce p53. Also, two hepatotoxic compounds (carbon development (6): loss of functional p53 may lead to gene tetrachloride, D-galactosamine) did not induce p53. Other mutations, chromosomal aberrations and other genetic alteracompounds that induced p53 in the rat liver were tions implicated in tumour development; however, p53 may 2-aminofluorene (administered by drinking water for two also, paradoxically, play an important role in the selection of weeks) and tris-(2,3-dibromopropyl)phosphate. Benzo[a]-cells which have lost functional p53 (25). Thus, exposure pyrene did not induce p53. N-Hydroxy-2-acetylaminofluoof the human skin to UV may lead to the clonal outgrowth of rene, aflatoxin B1, and diethylnitrosamine are potent hepcells with mutated p53 because proliferation of normal cells atic tumour promoters. At the same time, they induce p53 is blocked by the expression of wild type (wt) p53 by UVprotein expression and inhibit proliferation of normal hepatocytes. Because this is not observed with non-hepatoradiation in these cells (21). A similar mechanism has been carcinogenic analogues, it suggests an involvement of p53 suggested for the selection of p53 negative cells in solid expression in hepatic tumour promotion. A possible mechtumours by the induction of wt p53 by hypoxia (26). The anism is discussed.
clonal outgrowth of p53 negative cells is regarded as a very important step in tumour promotion/progression because it greatly increases the chance that cells are induced with Introduction additional genetic alterations. Clonal expansion of preneoplastic cells also occurs during The tumour suppressor gene p53 plays an important role in the process of experimental hepatocarcinogenesis in rats. Two regulation of the cell cycle and in the maintenance of genomic possible mechanisms have been proposed for such clonal integrity after induction of genetic damage. Studies in cell expansion. The first is selective stimulation of initiated, preneoplastic cells, as may occur during promotion with com-the rats were killed, the liver was removed and immediately frozen in sequent induction of p21 waf1/cip1 , leading to blockage of the liquid nitrogen.
cell cycle in the G1-or S-phase (3).
Measurement of alanine aminotransferase (ALT) activities in serum
In this study, we have investigated if hepatocarcinogens Blood taken from the rats was allowed to clot and centrifugated for 15 min increase p53 levels in the rat liver compared to non-hepato- Biotech GmbH, Melsungen, Germany), frozen in aliquots of 1 ml in liquid sodium deoxycholate, were from Janssen Chimica, Beerse, Belgium. Bovine nitrogen and stored at -80°C. After thawing on ice, new trypsin inhibitor and serum albumin (fraction V), propidium iodide, phenylmethylsulfonyl fluoride PMSF [final concentration 0.01% (w/v) and 1 mM respectively] were added, (PMSF), trypsin inhibitor type II-T ( from turkey egg white), and protein A-DNA was sheared by vortexing 5ϫ10 s (the vials were kept in between on sepharose beads were from Sigma Chemical Company, St Louis, MO, USA. ice). After sonication (4ϫduring 10 s on ice (Vibra cell, Sonic and Materials Nonidet P-40 was from Boehringer Mannheim GmbH, Mannheim, Germany.
Inc, Darburry, USA; small tip: diameter 0.5 cm, amplitude 60) the homogenates Paraformaldehyde and triethanolamine were from Merck-Schuchardt, Darmwere frozen in liquid nitrogen in aliquots. The protein content of the stadt, Germany. Prestained protein markers were from New England Biolabs, homogenate was determined by the method of Lowry et al. (43) . Beverly, MA, USA.
Protein A-sepharose beads used for immunoprecipitation were activated as follows: 1 g of dried beads was suspended in 4 ml of borate buffer [0.1 M Antibodies boric acid, 0.1% (v/v) Nonidet P-40, 3.1 mM sodium azide, adjusted to PAb 122 mouse p53 antibody hybridoma supernatant (39) was provided by pH 8.0 with NaOH] and mixed for 1 h. After centrifugation (15 s at the Department of Medical Biochemistry, Leiden University. CM-1 rabbit p53 15 000 g) borate buffer was removed and the beads were resuspended in antibody was from Novocastra Laboratories Ltd., Newcastle, UK. Mouse p53 borate buffer to obtain a 10% (w/v) suspension, and stored at 4°C. A 600 µl antibody PAb 240 and proliferating cell nuclear antigen (PCNA) antibody sample of undiluted p53 antibody PAb 122 solution was mixed for 1 h at 4°C PC-10 were provided by Santa Cruz Biotechnology Inc., Santa Cruz, CA, with 600 µl of 2ϫ concentrated IPB.7 buffer and 60 µl of the 10% (w/v) USA. Goat anti-mouse horseradish peroxidase (HRP) labelled antibody was protein A sepharose beads suspension. After centrifugation (15 s at from Rockland Laboratories, Gilbertville, PA, USA. Protein A, peroxidase-15 000 g), the antibody solution was removed and the beads were washed linked was from Amersham International plc., Buckinghamshire, UK.
twice with 400 µl IPB.7 by centrifugation (15 s at 15 000 g) and resuspension Animals and treatments in 400 µl of IPB.7. After the last centrifugation step, 60 µl IPB.7 was added and this solution was used for 6 immunoprecipitations. Male Wistar (outbred-WU) rats (190-210 g) from Charles River Wiga GmbH, For the immunoprecipitation of liver supernatants, 10 µl antibody-coated Sulzfeld, Germany, were used. The rats were housed in Macrolon cages on protein A-sepharose beads suspension was added to liver homogenate constandard hardwood bedding and had free access to food and tap water. An taining 5.0 mg of protein, and the solution was rotated (14 rpm) for 3 h at alternating 12 h light and dark cycle was maintained. The cages were kept 4°C. The protein A-sepharose beads were recovered by centrifugation under controlled airflow conditions to prevent contamination of the animal (15 s at 15 000 g) and washed 4ϫ with IPB.7, by centrifugation (15 s at rooms with carcinogens.
15 000 g) and resuspended in 400 µl IPB.7. After the final wash, the pellet N-OH-AAF, N-OH-AABP, Tris-BP, and AFB1, dissolved in dimethyl sulwas resuspended in 50 µl IPB.7 and 30 µl electrophoresis sample buffer phoxide (DMSO) (1 ml/kg) were administered by i.p. injection at doses of 60 [9.2% (w/v) sucrose, 2,85 µM 2-mercaptoethanol, 1 mg/ml bromophenol and 180 µmol/kg body wt (N-OH-AAF), 120 µmol/kg (N-OH-AABP), blue and 8% (w/v) SDS] and boiled for 5 min. After centrifugation (2 min at 250 µmol/kg (Tris-BP), or 0.320 and 0.800 µmol/kg (AFB1). DEN (245 µmol/ 15 000 g) the proteins were separated by SDS-polyacrylamide gel electrophorkg and 980 µmol/kg), EMS (2400 µmol/kg), and galactosamine (1900 µmol/ esis (PAGE) (method of Laemmli, 44) on 9% gels for 45 min at 200 V (7 kg), were dissolved in saline and injected i.p. (2 ml/kg). B[a]P (317 µmol/kg) cm gels) or 4-5 h on 35 mA (20 cm gels). The proteins were transferred for was dissolved in corn oil and injected i.p. (4 ml/kg). CCl 4 was diluted with corn 2 h at 400 mA to a 0.45 µm polyvinylidenedifluoride (PVDF) microporous oil to a 25% v/v solution and given orally at a dose of 1 ml CCl 4 /kg. Control rats membrane (Immobilon PVDF transfer membrane, Millipore corporation, received saline (2 ml/kg), DMSO (2 ml/kg) or corn oil (4 ml/kg), i.p. or orally.
Bedford, MA, USA) and processed for immunodetection using the ECLAt 24 h after the administration of the compounds 7 ml of blood was taken under detection method of Amersham. The primary antibodies used were PAb 122 diethyl ether anaesthesia and the liver was removed and immediately frozen in (dilution 1:10 of hybridoma supernatant), PAb 240 (dilution 1:1000) and liquid nitrogen.
CM-1 (dilution 1:1000) and the secondary antibody used was goat anti-mouse In another experiment rats were subjected to a 2/3 partial hepatectomy (PH) HRP labelled antibody (dilution 1:5000) or in case of CM-1, a 1:10 000 (40) 10 h after an injection with either 60 µmol/kg N-OH-AAF (dissolved in DMSO) or DMSO (1 ml/kg). At 9 or 24 h after the partial hepatectomy dilution of goat anti-rabbit HRP labelled antibody. Determination of PCNA Samples of liver homogenates containing 10 µg of protein in IPB.7 and sample buffer were separated by SDS-PAGE on 12% polyacrylamide gels (7 cm gels; 45 min on 200 V). After blotting to a PVDF membrane, the membrane was incubated with anti-PCNA antibody PC-10 (dilution 1:10 000) followed by incubation of a goat anti-mouse HRP labelled antibody (dilution 1:5000) and ECL-detection. The films were scanned with a flatbed scanner (Escom computer Vertriebs GmbH, model 6000C) using Aldus PhotoStyler 14 days, which has promotional activity in a Solt and Farber like protocol for hepatocarcinogenesis (49) , increased p53 Results expression in rat liver (Figure 1 ). In general, it is difficult to detect wt p53 protein in tissue
In order to obtain additional evidence that the p53 band because its level is very low due to a rapid turnover and low observed after N-OH-AAF administration on the Western blots levels of expression (7, (46) (47) (48) . In the rat liver, we could only represent p53, blots were also incubated with the primary detect p53 protein with an immunoprecipitation technique. We antibodies PAb 240 and CM-1. With PAb 122 and PAb 240, used the same antibody for immunoprecipitation and for using anti-mouse secondary antibody, two bands representing the primary anti-p53 antibody in Western blotting: mouse the heavy chains of PAb 122 used for immunoprecipitation monoclonal antibody PAb 122; therefore, the secondary antiwere again visible as explained above (Figure 2A and B) . body used in Western blotting (HRP labelled goat anti-mouse CM-1 is an antibody from a different host (rabbit); therefore, antibody) recognized PAb 122 bound to p53 on the blots as well another secondary antibody could be used in Western blotting as the heavy chains of PAb 122 used for immunoprecipitation (goat anti-rabbit HRP-labelled Ab) that does not recognize the ( Figure 1, upper two bands) . The p53 positive control, the antibody used for immunoprecipitation of p53. Thus, after the immunoprecipitate of the rat B1-1 cell line expressing a Val 135 blots were incubated with CM-1, the two upper bands from mutant of murine p53, showed a band of p53 beneath the two the PAb 122 antibody used for immunoprecipitation were bands of the heavy chains of PAb 122 used for immunoabsent. However, another large, non-specific band appeared precipitation. This band was absent in immunoprecipitates of on the films ( Figure 2C , upper band). P53 was detected by all liver homogenates from untreated rats.
three anti-p53 antibodies in immunoprecipitates of rat livers After administration of N-OH-AAF (60 µmol/kg) to rats, from N-OH-AAF treated animals ( Figure 2 ). PAb 240 normally p53 protein levels in rat liver were increased compared to recognizes the mutant conformation of the p53 protein or control animals that received only DMSO (Figure 1 ). Partial denatured wt p53 protein. Because all proteins are denatured hepatectomy (PH) also led to increased levels of p53: 9 h after during Western blotting, wt p53 is also recognized by PAb PH it was just detectable, but at 24 h after PH it was no more 240 on the blots. With all three anti-p53 antibodies, two bands detectable. Treatment with N-OH-AAF 10 h before PH resulted of p53 were visible. The lower band is probably due to in very high levels of p53 as compared to the levels after breakdown of p53 because it was only observed in immunoprecipitates that also contained p53. PH only (Figure 1) . Also, administration of 2-aminofluorene also induced p53 levels in rat liver ( Figure 3A and B). induction was already observed at the lowest dose that was used (0.32 µmol/kg), and was higher after administration of 0.80 µmol/kg ( Figure 3B ). No p53 induction was observed blotting (Figures 3, 4A and B) . Absence of acute cytotoxicity was determined by measuring ALT activities in serum, 24 h after administration of N-OH-AABP, a structural analogue of N-OH-AAF, or after EMS, a compound related to DEN, at the after administration of the compounds (Table I ) and confirmed by examination of liver slices stained with haematoxylin and highest dose tolerated by the rats ( Figure 4A ). No induction of p53 was observed after administration of B[a]P, although eosin. The finding that induction of p53 is unrelated to cytotoxicity is substantiated by the fact that D-galactosamine it is hepatocarcinogenic ( Figure 4B) ; however, p53 levels were increased after administration of Tris-BP ( Figure 4B ). The and CCl 4 at doses that cause severe damage in hepatocytes (Table I) did not increase p53 levels in rat liver ( Figure 5 ). induction of p53 does not seem to be related to the cytotoxicity of the compounds, because non-cytotoxic doses of N-OHIn order to investigate the effects of N-OH-AAF on blockage of the cell cycle, PCNA expression was determined after PH. AAF, AFB1 and Tris-BP showed a clear signal in Western p53 are reported to be low, and high levels are only found in cells expressing mutant forms of p53 (22). It is generally believed that mutant forms of p53 are stabilized and protected by a conformational change from the normal rapid degradation that occurs with wt p53. After exposure to certain genotoxic compounds or ionizing radiation, high levels of p53 may be induced in normal cells. This is probably due to stabilization of wt p53 by phosphorylation by specific kinases such as DNA-activated protein kinase (24). In this study, it was not possible to directly detect p53 in the rat liver by Western blotting or immunohistochemistry because levels of p53 are extremely low. Therefore, we have used immunoprecipitation to concentrate p53 before Western blotting. Unfortunately, this technique does not allow the determination of the cellular origin of p53 because current immunohistochemical techniques are not sensitive enough to measure wt p53 expression in paraffine or plastic embedded tissue. Therefore we cannot rigorously exclude a non-parenchymal localization of p53.
Our data show that the hepatocarcinogen N-OH-AAF while in untreated rats, p53 levels after PH are very low or not detectable. At the same time, N-OH-AAF inhibited PCNA expression in hepatocytes after PH. These data indicate that N-OH-AAF most likely blocks hepatocytes in the G1-phase of the cell cycle, consistent with the suggested role of p53 as a regulator of the cell cycle after induction of DNA-damage. Other mitoinhibitory (56,57) hepatocarcinogens that induce high levels of p53 in the rat liver are DEN and AFB1. Interestingly, the structural analogues N-OH-AABP and EMS did not induce p53 in the rat liver, although at the doses used they induce DNA damage to a similar extent as N-OH-AAF and DEN respectively (31, 34, 58, 59 ). They also did not inhibit PCNA expression after PH (results not shown). B[a]P did not induce p53 in the rat liver, which is rather surprising because B[a]P induces p53 expression in mouse skin (22). It also has tumour promotion activity in the rat liver (32), although less than N-OH-AAF and DEN; furthermore, it is hepatocarcinogenic after oral administration (5 doses of 120 µmol/kg administered on 5 consecutive days of every week induce tumours in every rat after 1.5 years; Dr E.D.Kroese, unpublished results). One explanation may be that the single dose of B[a]P used in this study does not induce enough e.g. such as recently suggested for 2,3,7,8-tetrachlorodibenzp-dioxin (TCDD), that may involve activation of the AHH PCNA is a marker for DNA synthesis in S-phase (49, 50) .
receptor (60) . PCNA expression was increased 3.5 fold in controls 24 h after Another genotoxic compound that induced p53 expression PH. At this time most of the hepatocytes are in S-phase in the rat liver was Tris-BP. This compound is clastogenic in and DNA-synthesis is maximal (51) . No increased PCNA the rat liver (37); however, it does not induce gene mutations expression was observed 9 h after PH, consistent with the fact in mammalian cells and is not an initiator of preneoplastic that the cells are still in G1-phase. Administration of N-OHhepatocytes like N-OH-AAF, DEN and N-OH-AABP (61). Its AAF (60 µmol/kg) 10 h before PH completely blocked the promotion activity and mitoinhibition in the rat liver have not normal increase in PCNA level that follows PH (Figure 6) . been tested. 
